Cargando…
Progress and Prospects on Vaccine Development against SARS-CoV-2
In December 2019, the outbreak of pneumonia caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to a serious pandemic in China and other countries worldwide. So far, more than 460,000 confirmed cases were diagnosed in nearly 190 countries, causing glo...
Autores principales: | Zhang, Jinyong, Zeng, Hao, Gu, Jiang, Li, Haibo, Zheng, Lixin, Zou, Quanming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349596/ https://www.ncbi.nlm.nih.gov/pubmed/32235387 http://dx.doi.org/10.3390/vaccines8020153 |
Ejemplares similares
-
α-Hemolysin-Aided Oligomerization of the Spike Protein RBD Resulted in Improved Immunogenicity and Neutralization Against SARS-CoV-2 Variants
por: Zou, Jintao, et al.
Publicado: (2021) -
High-throughput screening and evaluation of repurposed drugs targeting the SARS-CoV-2 main protease
por: Li, Yan, et al.
Publicado: (2021) -
Oral and intranasal vaccines against SARS‐CoV‐2: Current progress, prospects, advantages, and challenges
por: Kar, Sanchita, et al.
Publicado: (2022) -
Research progress on vaccine efficacy against SARS-CoV-2 variants of concern
por: Bian, Lianlian, et al.
Publicado: (2022) -
Vaccination induces rapid protection against bacterial pneumonia via training alveolar macrophage in mice
por: Gu, Hao, et al.
Publicado: (2021)